Mongolia Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mongolia Healthcare Journal.

Press releases published on June 2, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution
Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults
BriaCell Therapeutics Announces Closing of Offering
Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dianthus Therapeutics Announces Inducement Grants  Under Nasdaq Listing Rule 5635(c)(4)
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
J-Star Holding Outlines Foundational Milestones Supporting Proposed Baytown Battery Manufacturing Facility
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics
KORTUC Launches Global Cervical Cancer Study, Expanding Pipeline to Second Indication
Legend Senior Living® Expands Pennsylvania Footprint with Three Hemsley House Communities in Malvern, Dresher, and North Wales
Physicians Subjected to Unreliable ‘Lie-Detector’ Tests, according to the Journal of American Physicians and Surgeons
Adverse Effects of COVID Vaccine on Musculoskeletal Conditions Need Research, according to the Journal of American Physicians and Surgeons
Allsup Employment Services Highlights Ticket To Work Protection As SSA Centralizes Medical Disability Reviews
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share

Share this page:

Sign up for:

Mongolia Healthcare Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.